DANICA KIRKALINDA A. JOHNSON - Washington Examiner

DANICA KIRKALINDA A. JOHNSON

Read the latest stories and analysis from DANICA KIRKALINDA A. JOHNSON.

An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014. The board of pharmaceutical company AstraZeneca on Friday rejected drug maker Pfizer's sweetened takeover offer. Pfizer earlier in the day said it is offering 50 pounds ($84) a share in cash and stock, a 7.3 increase on a previous bid. The offer values AstraZeneca at $106 billion. (AP Photo/Matt Dunham)

AstraZeneca rejects sweetened Pfizer takeover bid

DANICA KIRKALINDA A. JOHNSON · May 2, 2014 9:34 pm

Pfizer still pursuing AstraZeneca after 2nd rebuff

Pfizer still pursuing AstraZeneca after 2nd rebuff

DANICA KIRKALINDA A. JOHNSON · April 28, 2014 6:59 pm

1

Page 1 of 1